BCL2 and cancer: Multidrug resistance (MDR) in cancer cells can be overcome by selectively inhibiting Bcl-2, resulting in cell cycle arrest, senescence, and eventual cell death in response to radiotherapy and chemotherapy (Tang et al., 2020; Wang et al., 2020).